--Myriad Genetics, Inc., a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian Donnelly as chief commercial officer, effective May 1, 2025.

Brian Donnelly, better known as KAWS, has developed one of the most instantly recognizable visual languages in contemporary art. Rooted in imagery from pop culture—namely cartoons, characters, and ...

Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer Provided by GlobeNewswire Apr 7, 2025 12:00pm. SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.

SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian ...